Simultaneous quantification of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry

Journal of Chromatography A

Volumn 1163, Issue 1-2, 2007, Pages 318-327

  Lowe, Ross H ^a   Karschner, Erin L ^a   Schwilke, Eugene W ^a   Barnes, Allan J ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cryofocusing; Gas chromatography mass spectrometry; Plasma; Tetrahydrocannabinol; Two dimensional chromatography

Indexed keywords

CARBOXYLIC ACIDS; GAS CHROMATOGRAPHY; MASS SPECTROMETERS; PLASMA (HUMAN); SOLVENT EXTRACTION;

CRYOFOCUSING; TETRAHYDROCANNABINOL; TWO-DIMENSIONAL CHROMATOGRAPHY;

POLYCYCLIC AROMATIC HYDROCARBONS;

11 HYDROXYDRONABINOL; ACETONITRILE; DRONABINOL; TETRAHYDROCANNABINOLIC ACID; TRIMETHYLSILYL DERIVATIVE; 11 HYDROXY DELTA(9) TETRAHYDROCANNABINOL; 11 NOR DELTA(9) TETRAHYDROCANNABINOL 9 CARBOXYLIC ACID; 11-HYDROXY-DELTA(9)-TETRAHYDROCANNABINOL; 11-NOR-DELTA(9)-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID; DRUG DERIVATIVE; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; GAS CHROMATOGRAPHY; HUMAN; ION MONITORING; MASS SPECTROMETRY; OPTICAL RESOLUTION; PRECIPITATION; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ASSAY; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; VALIDATION PROCESS; BLOOD; MASS FRAGMENTOGRAPHY; METHODOLOGY; REPRODUCIBILITY;

CHROMATOGRAPHY, GAS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; REPRODUCIBILITY OF RESULTS; TETRAHYDROCANNABINOL;

EID: 34547828152     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2007.06.069     Document Type: Article

References (35)

1. Nadulski T., Pragst F., Weinberg G., Roser P., Schnelle M., Fronk E.M., and Stadelmann A.M. Ther. Drug Monit. 27 (2005) 799
2. Pertwee R.G. Int. J. Obes. 30 Suppl. 1 (2006) S13
3. Maurer H.H., Sauer C., and Theobald D.S. Ther. Drug Monit. 28 (2006) 447
4. Guy G.W., Whittle B.A., and Robson P.J. The Medicinal Uses of Cannabis and Cannabinoids (2004), Pharmaceutical Press, London
5. Blake D.R., Robson P., Ho M., Jubb R.W., and McCabe C.S. Rheumatology (Oxford) (2005)
6. Notcutt W., Price M., Miller R., Newport S., Phillips C., Simmons S., and Sansom C. Anaesthesia 59 (2004) 440
7. Rog D.J., Nurmikko T.J., Friede T., and Young C.A. Neurology 65 (2005) 812
8. Wade D.T., Makela P.M., House H., Bateman C., and Robson P. Mult. Scler. 12 (2006) 639
9. Wade D.T., Makela P., Robson P., House H., and Bateman C. Mult. Scler. 10 (2004) 434
10. Mechoulam R., and Hanu L. Pain Res. Manage. 6 (2001) 67
11. Brady C.M., DasGupta R., Dalton C., Wiseman O.J., Berkley K.J., and Fowler C.J. Mult. Scler. 10 (2004) 425
12. Russo E., and Guy G.W. Med. Hypotheses 66 (2006) 234
13. Sidney S. J. Clin. Pharmacol. 42 (2002) 64S
14. Abrams D.I., Hilton J.F., Leiser R.J., Shade S.B., Elbeik T.A., Aweeka F.T., Benowitz N.L., Bredt B.M., Kosel B., Abert J.A., Deeks S.G., Mitchell T.F., Mulligan K., Bacchetti P., McCune J.M., and Schambelan M. Ann. Intern. Med. 139 (2003) 258
15. Curran H.V., Brignell C., Fletcher S., Middleton P., and Henry J. Psychopharmacology (Berl) 164 (2002) 61
16. Lundqvist T. Pharmacol. Biochem. Behav. 81 (2005) 319
17. Chang L., Yakupov R., Cloak C., and Ernst T. Brain 129 (2006) 1096
18. Rogers R.D., and Robbins T.W. Curr. Opin. Neurobiol. 11 (2001) 250
19. Ashton C.H. Br. J. Anaesth. 83 4 (1999) 637
20. Wachtel S.R., ElSohly M.A., Ross S.A., Ambre J., and de Wit H. Psychopharmacology (Berl) 161 (2002) 331
21. Nicholson A.N., Turner C., Stone B.M., and Robson P.J. J. Clin. Psychopharmacol. 24 (2004) 305
22. Huestis M.A. In: Pertwee R.G. (Ed). Handbook of Experimental Pharmacology vol. 168 (2005), Springer, New York p. 657
23. Huestis M.A., Elsohly M., Nebro W., Barnes A., Gustafson R.A., and Smith M.L. Ther. Drug Monit. 28 (2006) 540
24. Musshoff F., and Madea B. Ther. Drug Monit. 28 (2006) 155
25. Huestis M.A., and Cone E.J. Int. Assoc. Forensic Toxicologists (1992) 334
26. Huang W., Moody D.E., Andrenyak D.M., Smith E.K., Foltz R.L., Huestis M.A., and Newton J.F. J. Anal. Toxicol. 25 (2001) 531
27. Moore C., Guzaldo F., and Donahue T. J. Anal. Toxicol. 25 (2001) 555
28. Nadulski T., Sporkert F., Schnelle M., Stadelmann A.M., Roser P., Schefter T., and Pragst F. J. Anal. Toxicol. 29 (2005) 782
29. Gustafson R.A., Moolchan E.T., Barnes A., Levine B., and Huestis M.A. J. Chromatogr. B 798 (2003) 145
30. Steinmeyer S., Bregel D., Warth S., Kraemer T., and Moeller M.R. J. Chromatogr. B 772 (2002) 239
31. Saito T., Wtsadik A., Scheidweiler K.B., Fortner N., Takeichi S., and Huestis M.A. Clin. Chem. 50 (2004) 2083
32. ElSohly M.A., deWit H., Wachtel S.R., Feng S., and Murphy T.P. J. Anal. Toxicol. 25 (2001) 565
33. Moore C., Rana S., Coulter C., Feyerherm F., and Prest H. J. Anal. Toxicol. 30 (2006) 171
34. Fritch D.F., and Quimby B.D. Application Note (2006), Agilent Technologies p. 1
35. Scurlock R.D., Ohlson G.B., and Worthen D.K. J. Anal. Toxicol. 30 (2006) 262